CFDE Data Portal | Search NUTM2B-AS1

	Label	Description
	NUTM2B-AS1 associations Collection (Entity type)	Associations for NUTM2B-AS1_associations
	NUTM2B-AS1 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	NUTM2B-AS1 Gene (Entity type)	ENSG00000225484 - NUTM2B antisense RNA 1
	GSE113655 phenol 1 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE147876,GSE147877 2 V 7 ENZALUTAMIDE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE143782 calcitriol 7 v 11 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE155031 catechin SH-SY5Y 5 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE249544 GSE249637 temozolomide 9 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE149632 dopamine 0 v 6 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE199107 tryptophan 0 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS

NUTM2B-AS1 associations

Associations for NUTM2B-AS1_associations

NUTM2B-AS1 associations.tsv

A file from IDG as part of the Harmonizome project

NUTM2B-AS1

ENSG00000225484 - NUTM2B antisense RNA 1

GSE113655 phenol 1 v 2 human dn

A Gene Set from LINCS

GSE147876,GSE147877 2 V 7 ENZALUTAMIDE HUMAN UP

A Gene Set from LINCS

GSE143782 calcitriol 7 v 11 human dn

A Gene Set from LINCS

GSE155031 catechin SH-SY5Y 5 v 3 human up

A Gene Set from LINCS

GSE249544 GSE249637 temozolomide 9 v 5 human dn

A Gene Set from LINCS

GSE149632 dopamine 0 v 6 human up

A Gene Set from LINCS

GSE199107 tryptophan 0 v 5 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.